Xalud Therapeutics, Inc.
Biotechnology company · Charlottesville, Virginia, United States
Xalud Therapeutics, Inc. is a biotechnology company headquartered in Charlottesville, Virginia, United States. It has reported private securities offerings to the US SEC, most recently $18 million sold in a notice filed in 2021.
Profile compiled from public records. Is this your company? Request a correction or update
Xalud Therapeutics at a glance
Typebiotechnology company
HeadquartersCharlottesville, Virginia, United States
SEC CIK1646982
What does Xalud Therapeutics do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $18.2 million sold (2021).
Frequently asked questions about Xalud Therapeutics
Where is Xalud Therapeutics headquartered?
Xalud Therapeutics, Inc. is headquartered in Charlottesville, Virginia, United States.
What does Xalud Therapeutics do?
Xalud Therapeutics, Inc. is a biotechnology company.
Similar companies
- Hemoshear Therapeutics, Inc.Charlottesville, Virginia, United States
- Contraline, Inc.Charlottesville, Virginia, United States
- Barron Associates, Inc.Charlottesville, Virginia, United States
- SoundPipeCharlottesville, Virginia, United States
- Atelerix Life Sciences Inc.Charlottesville, Virginia, United States
- Gene Solutions LLCCharlottesville, Virginia, United States
- Zielbio, Inc.Charlottesville, Virginia, United States
- Cavion, Inc.Charlottesville, Virginia, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences